Stress (Tako-tsubo) cardiomyopathy in critically-ill patients

Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):189-96. doi: 10.1177/2048872614547686. Epub 2014 Sep 8.

Abstract

Background: Stress cardiomyopathy (SC) is a transient ventricular dysfunction rarely described in the critical care setting.

Objective: To evaluate the mechanisms, incidence, treatment and prognosis of SC.

Method: This is a retrospective observational study of every critically-ill patient admitted to the ICU over a period of two years.

Results: Among 1314 patients admitted in the ICU, 20 patients (1.5%) were diagnosed with SC. A total of 249 patients experienced cardiogenic shock, whereas 8% were suffering from SC. SC was suspected because of hemodynamic impairment (80% of cases), ECG modifications (15%) and/or dyspnea (15%). SC was apical (typical Tako-tsubo) in 90% and atypical in 10% of cases. Several mechanisms or conditions may explain the occurrence of SC and are may be combined: catecholamine toxicity (45%), psychological stress, seizures or neurological impairment (35%), non-epicardial coronary ischemia (20%) and left ventricular outflow track (LVOT) obstruction (10%). SC could have indirectly caused death by worsening heart failure in three patients and arrhythmias were seen in 40% of patients. SAPS2, renal impairment, malnutrition, norepinephrine infusion and thrombocytopenia were associated with death in the univariate analysis. Catecholamines were required in 85% and intra-aortic balloon pump in 20% of patients.

Conclusions: SC is a rare reversible cardiac impairment in the critically-ill patient that can induce arrhythmias and cardiogenic shock. The likely mechanisms are combined: catecholamine toxicity, stress or neurological involvement and less frequently ischemia or LVOT obstruction.

Keywords: Tako-tsubo; brain–heart connection; catecholamine; critical illness; seizures; stress cardiomyopathy.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers / metabolism
  • Catecholamines / metabolism
  • Critical Illness*
  • Electrocardiography
  • Female
  • Hemodynamics
  • Humans
  • Incidence
  • Intensive Care Units
  • Intra-Aortic Balloon Pumping / methods
  • Male
  • Middle Aged
  • Noninvasive Ventilation / methods
  • Prognosis
  • Retrospective Studies
  • Reunion / epidemiology
  • Risk Assessment
  • Risk Factors
  • Takotsubo Cardiomyopathy / diagnosis
  • Takotsubo Cardiomyopathy / mortality*
  • Takotsubo Cardiomyopathy / physiopathology
  • Takotsubo Cardiomyopathy / therapy*
  • Treatment Outcome

Substances

  • Biomarkers
  • Catecholamines